… Allogeneic hematopoietic stem cell transplantation (HSCT) is the cornerstone of consolidation
therapy for intermediate and high-risk AML and the only curative therapy for advanced …

… have contributed to improvement in transplantation outcomes. To address this … of adults
with acute myeloid leukemia in first or second complete remission who underwent allogeneic …

… The decision to proceed to allogeneic stem cell transplantation (HSCT) is the mainstay of
precision medicine in acute myeloid leukemia (AML) patients younger than 60 years achieving …

… Transplantation (CIBMTR) database comprised the alloHCT cohort. As reporting of allogeneic
stem cell transplant … set includes almost all such transplants performed in the US during …

… “myth of the second remission of acute leukemia in the adult,… For relapsed B-cell acute
lymphoblastic leukemia (B-ALL), … to proceed to allogeneic hematopoietic stem cell transplantation (…

… Large series of patients with acute myelogenous leukemia (AML) after ex vivo T cell-depleted
(TCD) allogeneic hematopoietic stem cell transplantation (allo-HSCT) have not been …

… neoplasms (t-MN) include both therapy-related myelodysplastic syndromes as well as
therapy-related acute myeloid leukemia. These two entities were grouped together in the World …

… The optimal myeloablative conditioning (MAC) regimens in adult patients with acute
myeloid leukemia (AML) undergoing allogeneic hemopoietic stem cell transplantation (allo-HSCT) …

… The prognosis of patients with acute myeloid leukemia (AML) is dismal after experiencing …
outcomes of allogeneic hematopoietic cell transplantation (HCT) for 192 adults with AML in …

… Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid
leukemia or myelodysplastic syndromes: myth … after allogeneic stem cell transplantation from …